These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Undesirable adverse effects of the antirheumatic pharmacotherapy on the eyes]. Verraz R Arch Sci Med (Torino); 1974; 131(3):167-72. PubMed ID: 4463933 [No Abstract] [Full Text] [Related]
11. [Corticosteroids and the risk of glaucoma]. van Boxtel LA; Hardus PL; Al Hassan WS; van Voorst Vader PC; Jansonium NM Ned Tijdschr Geneeskd; 2005 Nov; 149(45):2485-9. PubMed ID: 16304883 [TBL] [Abstract][Full Text] [Related]
14. Advances in ocular corticosteroid therapy. Levine SB; Leopold IH Med Clin North Am; 1973 Sep; 57(5):1167-77. PubMed ID: 4601487 [No Abstract] [Full Text] [Related]
15. Ocular complications in the treatment of joint disease. Giles CL Mich Med; 1971 Jun; 70(13):531-4. PubMed ID: 5567615 [No Abstract] [Full Text] [Related]
16. [Complications of local pharmacotherapy in ophthalmology]. Mozherenkov VP; Ukhaneva GL Vestn Oftalmol; 1985; 101(1):62-5. PubMed ID: 2858932 [No Abstract] [Full Text] [Related]
17. [Ocular complications after local corticotherapy]. Bloch-Michel E Rev Prat; 1977 Dec; 27(59):4113-6, 4119. PubMed ID: 605343 [No Abstract] [Full Text] [Related]
18. The pharmacological basis for the rational use of topically applied corticosteroids. Greaves MW Pharmacol Physicians; 1969 Oct; 3(10):1-5. PubMed ID: 5821948 [No Abstract] [Full Text] [Related]
19. [Eye and corticosteroid's use]. Fel A; Aslangul E; Le Jeunne C Presse Med; 2012 Apr; 41(4):414-21. PubMed ID: 22377461 [TBL] [Abstract][Full Text] [Related]